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Abstract
Background: Knowledge of the distribution of human papillomavirus (HPV) genotypes among women with
cervical lesion and in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. There is
no published data concerning HPV and cervical abnormalities in Sudan. This study aimed to define the prevalence
of HPV and its subtypes in the cervical smears of women presenting with gynecological complains at Omdurman
Military Hospital, Sudan.
During the period between March 2003 and April 2004, 135 cervical smears collected from these women, were
screened using cytological techniques, and analysed by PCR for (beta)-globin and HPV DNA using gel electrophor-
esis and ELISA.
Results: Of these 135 smears, there were 94 (69.3%) negative, 22 (16.3%) positive for inflammation, 12(8.9) mild
dyskaryosis, 5 (3.7) moderate dyskaryosis and 2 (1.8) severe dyskaryosis. There were 60.7% ß. globin positive
samples for HPV indicating DNA integrity. HPV DNA was identified in three samples (2.2%) by gel electrophoresis
and. was positive in four samples (2.9%) as single and multiple infections by PCR-ELISA. The high risk HPV types 16
and 58 were identified in one sample as a mixed infection. The low risk HPV types 40 and 42 were also found as a
mixed infection in another patient. HPV types 58 and 42 were identified in the other two patients.
Conclusion: HPV type distribution in Sudan appears to differ from that in other countries. The HPV genotypes
identified were not associated with cancer.
Background
Human papilloma virus (HPV) is a cause of cervical
cancer and condylomata acuminata [1]. Many sexually
active populations in many parts of the world have been
infected with HPV during their lifetime [2], most HPV-
infected individuals eliminate the virus without develop-
ing clinical symptoms [3]. Nearly 100 HPV types have
been molecularly identified and about 40 of these can
infect the ano-genital tract [4]. On the basis of their
oncogenic potential, most of these genital HPV types
have been classified as high or low risk for causing cer-
vical cancer. The high-risk types, especially HPV 16 and
18 are implicated in the development of cervical intrae-
pithelial neoplasia and cervical carcinoma. The low-risk
types (HPV 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, 81, and
CP6108) can cause mild cervical dysplasia but are rarely
associated with severe cervical dysplasia or cervical car-
cinoma [5,6] Women found to be positive for high-risk
HPV were at increased risk of developing CIN3 than
those with a negative HPV test [7]. However infection
by HPV does not always lead to malignant and pre-
malignant change development and populations may
carry HPV types that are frequently associated with
cancer, and not develop invasive lesions [8]. Thus, the
prevalence of HPV in a population of people is invari-
ably greater than the number of women who develop
cervical lesions. HPV type distribution and cervical can-
cer has been studied in other African countries [3,9].
However, there is as yet no published data from The
Sudan. Thus, in the present study GP5+/GP6+-PCR EIA
[*] was used to identify the prevalence of HPV geno-
types among women attending the Gynaecology clinic in
Omdurman Military Hospital, Sudan.
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Methods
During the period of February 2003 through May 2004,
a cross-sectional study was conducted among, women
presenting to the gynecological clinic with symptoms of
vaginal discharge, inter-menstrual bleeding, and post-
coital bleeding were approached to participate in the
study. After informed consent, questionnaires were con-
ducted to gather socio-demographic, medical and gyne-
cological characteristics. Then cervical smears were
collected using the standard Szalay cyto-spatula. Cells
were initially used to prepare a Pap smear and the
remaining cells on the spatula were eluted in Tris HCl
buffer PH 8.0. A cell pellet was obtained by centrifuga-
tion, re-suspended in 2 ml Tris HCl buffer pH 8.0 and
frozen at -20°C until HPV analysis using PCR-EIA in
Cardiff, United Kingdom. Cytology and HPV DNA
detection Pap smears were prepared with Papanicolaou
stain, screened by cyto -screener and positive results
revised and confirmed. To target DNA, samples were
pre-screened by polymerase chain reaction (PCR) using
ß-globin specific primers as described previously [10].
Human papilloma virus infections were analyzed by gen-
eral primer GP5+/6+ mediated PCR enzyme immunoas-
say (EIA) as described by Jacobs et al [10] that its used
to detect a broad spectrum of human papilloma virus
(HPV) genotypes including the high-risk groups (HPV-
16,18,31,33,35,39,45,51,52,56,58,59,66, 68 and 73) and
low risk groups (HPV-6,11,40,42,43 and 44). Moreover,
amplification products were analyzed for individual HPV
subtypes.
Results
The mean age of the women was 33.18 years (range 17-
60 years). Cervical smears had normal cytology in 94
(69.6%) out of 135 patients. The rest of the patients had
22(16.3) inflammatory changes 12(8.9) mild dyskaryosis,
5 (3.6) moderate dyskaryosis and 2 (1.5) severe dyskar-
yosis. Human DNA was detected in 82 (60.7%) out of
135 samples using ß globin PCR. Three samples (2.3%)
were positive for HPV DNA as determined by gel elec-
trophoresis; however these samples were not reactive
with ELISA for HR and LR groups, suggesting novel
HPV subtypes. The cytological findings of these two
samples were reported as moderate dyskaryosis and
severe dyskaryosis. Nine samples had a reactive result
with HPV DNA using ELISA method. Three samples
showed reactive result with HPV 58, these were found
in samples that were reported as moderate dyskaryosis
and one with mild dyskaryosis. Another two samples
showed reactive result with HPV types 16 and 42, the
cytological result of these were, inflammation and normal
cytology respectively. The other four samples were reac-
tive with ELISA and gel electrophoresis for HPV DNA.
Those patients showed infection with general high risk
(HR) cocktails group and general low risk (LR) cocktails
group, table 1. After the sub typing of these two groups,
two mixed (low and high risk group) infections were
found. Type 16 and 58 were identified in one sample that
is reported cytologically as moderate dyskaryosis, and
type 40 and 42 in another single sample with negative
cytological result. The most common high risk infection
in our study group was type 58. And in the low risk the
most common was type 42, Table 2.
Discussion
This is the first study we are aware of investigating HPV
infection among Sudanese women and one of the few
studies that used the PCR-EIA technique (general pri-
mer (GP5+/GP6+) and ELISA) in Sub-Saharan Africa.
Previously Ibrahim and his colleagues failed to isolate
HPV DNA in a small number of oral cancer tissue sam-
ples using classical PCR techniques in Sudanese patients
[11]. GP5+/bio-GP6+ PCR-EIA was the method used in
Table 1 cervical pathology and HPV prevalence in
Sudanese women
Cytology Result HPV DNA HR HPV DNA LR Total
Positive Negative Positive Negative
Negative 0(00%) 94(100%) 3(3.2%) 91(96.8%) 94(69.3%)
Inflammation 1(4.5%) 21(95.5%) 0 (00%) 22(100%) 22 (16.3)
Mild dyskaryosis 1(8.4%) 11 (91.6) 0 (00%) 12(100%) 12(8.9)
Moderate
dyskaryosis
4 (80%) 1 (20%) 0(00%) 5 (100%) 5(3.7)
Severe
dyskaryosis
0(00%) 2(100%) 0(00%) 2(100%) 2 (1.8)
Total 6 129 3 132 135
Key HR (High risk types), LR (Low risk types)
Table 2 Cervical pathology and HPV genotypes
HPV Types Negative Infection mild Moderate Severe Total
Infection with single HPV
HPV 58 1 1
HPV 16 1 1
HPV 58 1 1 2
HPV 42 1 1
Infection with mixed HPV
HPV 16 1 1
HPV 58 1 1
HPV 40 1 1
HPV 42 1 1
HPV DNA identified with Gel
HPV X 2 1 3
Total 1 3 1 6 1 12
Cytological results/HPV Genotypes
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the current study, which has a high sensitivity and speci-
ficity for HPV/HPV type detection. In this study, 60.7%
of samples were ß globin positive, and the rest were non
reactive. Perhaps the cold chain was interrupted some-
where during samples transfer. Only three samples were
classified as HPV X that is HPV/DNA positive with gel
electrophoresis and genotype negative with ELISA.
There may be some unidentified HPV types or the types
of HPV are not within the probe cocktail of the 15 high
risks or the 6 low risk group. A similar result was
obtained in other African countries e.g. Mozambique
[12] in which HPV specific types could not be identified
in 19% of the HPV positive cases; they related this fail-
ure to the limited number of HPV specific probes used.
In Uganda a similar result was obtained where they
identified and sequenced one other variant of HPV 16
called HPV 16 AF1 sequence [13].
HPV 58 was the most common type in the current
study. However, HPV 58 is considered a rare type, and
not commonly reported in most of Europe, both Ameri-
cas and Asian countries (14). Yet in Africa, this type
was observed e.g. east, central, west and South Africa
[14]. This finding could refer to an international differ-
ence in HPV distribution. On the other hand our results
were partially in agreement with Clifford et al., who
described the overall predominant role for HPV 16 and
HPV 18. We only identified HPV 16 and could not iso-
late HPV type 18 often the most common high risk type
[15]. All the high risk HPV genotypes identified were
associated with moderate dyskaryosis and CIN2. Interest-
ingly, our findings may be cautiously compared with the
results of other African countries. Firstly, a higher preva-
lence of HPV has been reported among women with HIV
[16] and we have recently reported low prevalence of
HIV among pregnant Sudanese women [17]. Secondly
there are many social and behavioral differences between
different settings e.g. male circumcision -which has been
reported to have low prevalence for HPV-is one of the
religious practices in central Sudan [18].
Conclusion
In summary this preliminary reported concerning HPV
types in Sudan will need to be extended to larger studies
in the future. Information about HPV types in Sudan
will be of great value to help the national health author-
ity and decision makers to introduce HPV vaccine in
Sudan. Further studies are also needed to identify the
association between HPV infection and cervical cancer.
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